Delhi High Court quashes Cipla’s appeal, says it can’t market generics of Novartis’ Onbrez Industry-The Economic Times — March 9, 2017 comments off The court said it can’t make a definitive conclusion that Novartis’ imports of Onbrez were insufficient to meet the demands COPD patients from the data that was submitted by Cipla and Novartis during the hearings.
